A randomized, double‐blind, placebo‐controlled trial of camicinal in Parkinson's disease

Background: Delayed gastric emptying may impair l‐dopa absorption, contributing to motor fluctuations. We evaluated the effect of camicinal (GSK962040), a gastroprokinetic, on the absorption of l‐dopa and symptoms of PD. Methods: Phase II, double‐blind, placebo‐controlled trial. Participants were ra...

Descripción completa

Detalles Bibliográficos
Autores principales: Marrinan, Sarah L., Otiker, Tal, Vasist, Lakshmi S., Gibson, Rachel A., Sarai, Bhopinder K., Barton, Matthew E., Richards, Duncan B., Hellström, Per M., Nyholm, Dag, Dukes, George E., Burn, David J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5838770/
https://www.ncbi.nlm.nih.gov/pubmed/29278279
http://dx.doi.org/10.1002/mds.27259

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5838770/
https://www.ncbi.nlm.nih.gov/pubmed/29278279
http://dx.doi.org/10.1002/mds.27259

Ejemplares similares